Abstract
Background: Mesenchymal stem cells (MSCs) are under consideration for myocardial ischemia-reperfusion (I/R) injury therapy, but their mechanism remain......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
